Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paragon 28 (DE:7GQ)
FRANKFURT:7GQ
Holding DE:7GQ?
Track your performance easily
7GQ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€5.10 - €13.50
Previous Close€7.2
Volume0.00
Average Volume (3M)227.00
Market Cap
€624.64M
Enterprise Value€681.75M
Total Cash (Recent Filing)$46.74M
Total Debt (Recent Filing)$110.55M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Nov 06, 2024EPS Estimate
-€0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,542,291
10 Day Avg. Volume0
30 Day Avg. Volume227
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)6.88
Price to Sales (P/S)2.93
Price to Cash Flow (P/CF)-16.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.90
Enterprise Value/Gross Profit3.95
Enterprise Value/Ebitda-39.43
Forecast
1Y Price Target
€13.00Price Target Upside80.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Paragon 28 News
PremiumCompany Announcements
Paragon 28 Announces New CFO and Operational Efficiency Plan
Bulls Say, Bears Say
Bulls Say
LeadershipThe company appointed a new CFO/EVP of Supply Chain Ops, Chadi Chahine, effective earlier this week.
Operational EfficiencyFNA announced an operational efficiency strategy to optimize its org structure, minimize costs, and preserve cash while maintaining revenue growth opportunities.
Product And Sales GrowthThere are no signs that FNA is slowing down from a vitality and commercial perspective, increasing producing rep count this Q while launching another 4 products since the Q1.
Bears Say
LiquidityThe company’s liquidity remains an overhang on the stock that likely does not ease until investors see meaningful improvement in cash flow.
Market CommentaryManagement noted that 2Q24 was 'choppy' with variability from week to week and as a result they lowered their annual revenue guidance.
Revenue GuidanceFNA lowered the high end of its FY24 revenue guidance which reduced the midpoint by $2m and implies a noticeable growth slowdown in 2H.
---
7GQ FAQ
What was Paragon 28’s price range in the past 12 months?
Paragon 28 lowest stock price was €5.10 and its highest was €13.50 in the past 12 months.
What is Paragon 28’s market cap?
Currently, no data Available
When is Paragon 28’s upcoming earnings report date?
Paragon 28’s upcoming earnings report date is Nov 06, 2024 which is in 66 days.
How were Paragon 28’s earnings last quarter?
Paragon 28 released its earnings results on Aug 08, 2024. The company reported -€0.152 earnings per share for the quarter, missing the consensus estimate of -€0.151 by >-€0.001.
Is Paragon 28 overvalued?
According to Wall Street analysts Paragon 28’s price is currently Undervalued.
Does Paragon 28 pay dividends?
Paragon 28 does not currently pay dividends.
What is Paragon 28’s EPS estimate?
Paragon 28’s EPS estimate is -€0.14.
How many shares outstanding does Paragon 28 have?
Paragon 28 has 83,542,290 shares outstanding.
What happened to Paragon 28’s price movement after its last earnings report?
Paragon 28 reported an EPS of -€0.152 in its last earnings report, missing expectations of -€0.151. Following the earnings report the stock price went up 2.778%.
Which hedge fund is a major shareholder of Paragon 28?
Among the largest hedge funds holding Paragon 28’s share is Graham Capital Management, L.P.. It holds Paragon 28’s shares valued at 88K.
---
Paragon 28 Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.15%
12-Months-Change
Fundamentals
Return on Equity
-39.76%
Trailing 12-Months
Asset Growth
3.20%
Trailing 12-Months
Company Description
Paragon 28
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, charcot, fracture fixation, hallux valgus, hammertoe, and flatfoot.
---
7GQ Company Deck
---
7GQ Earnings Call
Q2 2024
0:00 / 0:00
---
7GQ Stock 12 Month Forecast
Average Price Target
€13.00
▲(80.53% Upside)
Technical Analysis
Best Analysts Covering 7GQ
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
-15.31%
assigned a buy rating 23 days ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -15.31% per trade.
---